Variable effects of diabetes-related medications on SGLT2-induced eGFR changes in diabetic patients

Variable effects of diabetes-related medications on SGLT2-induced eGFR changes in diabetic patients - SGLT2-induced eGFR changes in diabetic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037043

Enrollment

200

Registered

2019-06-13

Start date

2019-01-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Men and women who were diagnosed with diabetes mellitus taking SGLT-2 inhibitor

Exclusion criteria

Exclusion criteria: Patients who fall under any of HbA1c> 11.0, use of steroids, use of immunosuppressant, use of NSAID, or other acute disease

Design outcomes

Primary

Measure	Time frame
The changes in eGFR over one year in diabetic patients using combination drugs given SGLT2 inhibitors	—

Countries

Japan

Contacts

Public ContactKoichi Kitamura

Tokyo Bay Urayasu Ichikawa Medical Center Department of Nephrology, Endocrinology and Diabetes

japan.koichi@gmail.com0473513101

Outcome results